Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Pain-Related Potential of Phoenixin as a Biomarker in Pediatric Burn Patients

NCT07858409 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.

NCT NCT07858409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07858409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Pain-Related Potential of Phoenixin as a Biomarker in Pediatric Burn Patients
Lead sponsor
Ankara City Hospital Bilkent
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
October 1, 2027
Enrollment
87 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, burn degree second, burn pain, children